Cacti Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-215,018
Closed -$35.9M 84
2019
Q2
$35.9M Buy
215,018
+2,009
+0.9% +$278K 2.77% 18
2019
Q1
$31.2M Buy
213,009
+723
+0.3% +$105K 2.51% 21
2018
Q4
$28.4M Buy
212,286
+982
+0.5% +$161K 2.49% 21
2018
Q3
$40.3M Buy
211,304
+750
+0.4% +$138K 2.98% 17
2018
Q2
$35.5M Buy
210,554
+1,802
+0.9% +$289K 2.87% 21
2018
Q1
$35.1M Sell
208,752
-11,986
-5% -$2.01M 2.95% 21
2017
Q4
$36.1M Sell
220,738
-594
-0.3% -$107K 2.92% 21
2017
Q3
$45.4M Buy
221,332
+22,384
+11% +$5.21M 3.84% 12
2017
Q2
$48.5M Buy
198,948
+2,028
+1% +$477K 4.35% 4
2017
Q1
$47.2M Buy
196,920
+2,600
+1% +$605K 4.16% 3
2016
Q4
$40.8M Buy
194,320
+4,045
+2% +$838K 3.85% 9
2016
Q3
$43.8M Buy
190,275
+3,025
+2% +$739K 4.47% 1
2016
Q2
$43.3M Buy
187,250
+2,213
+1% +$510K 4.63% 1
2016
Q1
$50.9M Sell
185,037
-328
-0.2% -$93.9K 5.47% 1
2015
Q4
$57.9M Hold
185,365
6.21% 1
2015
Q3
$50.4M Sell
185,365
-7
-0% -$2.15K 5.72% 1
2015
Q2
$56.3M Buy
185,372
+200
+0.1% +$59.7K 6.07% 1
2015
Q1
$55.1M Hold
185,172
5.83% 1
2014
Q4
$47.7M Buy
185,172
+2,794
+2% +$698K 5.38% 1
2014
Q3
$44M Buy
+182,378
New +$40.8M 5.31% 1

Other funds holding AGN

Cacti Asset Management's AGN Position: Q3 2019 in Review

Cacti Asset Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 215,018 shares — an estimated $35.9M sold.

Cacti Asset Management first reported a position in AGN in Q3 2014 and held it in 20 quarters. The position peaked at $57.9M in Q4 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Cacti Asset Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Cacti Asset Management sold 215,018 Allergan plc shares in Q3 2019, an estimated $35.9M.
  • Cacti Asset Management first reported a position in Allergan plc in Q3 2014 and held it in 20 quarters.
  • Cacti Asset Management's Allergan plc position peaked at $57.9M in Q4 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Cacti Asset Management's 13F filing for Q3 2019, filed 1 Oct 2019.